Video

How will sequestration affect American cancer care?

Publish date: June 7, 2013
By
Patrice Wendling

 

In an interview at the ASCO 2013 meeting, ASCO's chief medical officer, Dr. Richard Schilsky, discusses the negative impact federal spending cuts are having on physicians' care of cancer patients.

Recommended Reading

Which paclitaxel schedule works best for breast cancer?
MDedge Hematology and Oncology
Adding bevacizumab to chemo prolongs life in advanced cervical cancer
MDedge Hematology and Oncology
Sorafenib emerges as option for advanced thyroid cancer
MDedge Hematology and Oncology
Palbociclib continues on fast track to potential FDA approval
MDedge Hematology and Oncology
Novel genetic marker predicts pancreatic cancer risk
MDedge Hematology and Oncology
Ganetespib trial hints at survival benefit in lung adenocarcinoma
MDedge Hematology and Oncology
Donepezil fails to improve cognition after brain irradiation
MDedge Hematology and Oncology
Study confirms benefits of 10 years of tamoxifen
MDedge Hematology and Oncology
Weekly adjuvant paclitaxel for breast cancer has less toxicity
MDedge Hematology and Oncology
Gene mutations found in 22% of African American breast cancer patients
MDedge Hematology and Oncology